A critically ill patient had a major mitral paravalvular leak, failed device closure of the leak, and severe hemolytic anemia after a third mitral valve replacement. Echocardiography showed the Amplatzer occluder device completely displaced and swirled in the left atrial cavity. His condition was greatly improved after a fourth mitral valve replacement.
Introduction
As an alternative to surgical treatment, percutaneous transcatheter closure technique is typically employed in the management of congenital heart defects including atrial or ventricular septal defect, patent ductus arteriosus, and ruptured sinus of Valsalva w1, 2x. The practice of transcatheter closure of the paravalvular leak was started in 1987, by using the double-umbrella device developed by Rashkind and Cuaso w3x. Displacement of the Amplatzer occluder device is a rare complication, which occurred in 0.9-2.4% of the interventionally treated population with a congenital heart defect w4-6x. Only one case of displacement of the Amplatzer occluder device was reported subsequent to percutaneous closure of mitral paravalvular leak w7x.
Case report
A 65-year-old man, who had his third mitral valve replacement and subsequent paravalvular leak and failed device closure of the leak, recently developed severe hemolytic anemia, congestive heart failure, respiratory failure, renal failure, and klebsiella pneumonia bacteremia. He required prolonged ventilation through tracheostomy, multiple blood transfusion, and pacemaker for atrial fibrillation. He also had a history of diabetes, hypertension, ischemic heart disease, and glaucoma, etc. Laboratory tests (22 April 2008) showed that his hemoglobin was 8.7 gydl (normal range, 14-18 gydl), white blood cell count 22.94 Kyml (normal range, 4.8-10.8 Kyml), creatinine 2.81 mgydl (normal range, 0.67-1.17 mgydl), and lactate dehydrogenase *Corresponding author. Tel.: q972 3 5302710; fax: q972 3 5302410. E-mail address: shi_min_yuan@yahoo.com (S.-M. Yuan).
5133 Uyl (normal range, 230-480 Uyl). Echocardiography demonstrated mild wall motion abnormality, major mitral paravalvular leak, mild aortic valve stenosis, and mild tricuspid stenosis. Conservative treatments were not successful in improving his condition. He was referred to this department for surgical operation.
He was operated on under femorofemoral cardiopulmonary bypass on 4 June 2008. Preoperative echocardiography revealed a major posterior mitral paravalvular leak extending 0.8 cm in diameter, and the Amplatzer occluder device completely displaced and swirled in the left atrial cavity clockwisely ( Fig. 1 and Videos 1 and 2). The left atrium was approached through the right atrium-atrial septum route. The tricuspid valve was regurgitant, the Amplatzer occluder device was located in the left atrium, and the mitral paravalvular leak was at the posterior portion. No signs of infection were noted in the mitral position. The Amplatzer occluder device was taken out (Fig. 2) , and then the mitral valve was replaced with a 27 mm St. Jude Medical mechanical prosthesis (St. Jude Medical Inc., Minneapolis, MN, USA), and the tricuspid valve was repaired with a 32 mm Cosgrove-Edwards annuloplasty band (Edwards Lifesciences, Irvine, CA, USA). The cardiopulmonary bypass time was 228 min, and the cross-clamp time was 148 min.
The patient was hemodynamically stable and his condition was immediately improved after the operation. His hemoglobin was 9.5 gydl, and his lactate dehydrogenase recovered to the normal limit. He was transferred to the Fifth Department of Internal Medicine for further convalescence on the 13 postoperative day. 
Discussion
Paravalvular leak is a relatively common complication of heart valve replacement. It may cause cardiac dysfunction Downloaded from https://academic.oup.com/icvts/article-abstract/7/6/1131/655718 by guest on 25 December 2018 and severe anemia, and lead the patient to a surgical intervention w8x. The advent of the transcatheter closure technique makes such patients with a high anticipated risk avoid redo operation w8x. Currently, Amplatzer occluder devices have been popularly accepted as a promising alternative to open heart surgery. However, significant residual regurgitation is sometimes noted, and repeated intervention is necessary w1x. The etiology of the residual paravalvular leak was primarily considered to be the irregular crescentric shape of the defect w1x. In the present patient, the suture dehiscence due to his poor conditions, including diabetes, may have been vulnerable to the paravalvular leak. Other complications of the occluder devices include arrhythmias, thromboembolism, device embolization, perforation, valve obstruction, and unstable position of the device w8x.
Displacement of the Amplatzer occluder device is a rare complication of this interventional procedure. Only one case of occluder displacement after being deployed for mitral paravalvular leak was reported w7x. Size and location of the paravalvular leak, and presence of infection might be correlated with the stability of the occluder device. In addition, the device sitting on the atrial surface of the prosthesis was always moved by the eccentric regurgitant jet w7x. Such a complication requires surgical intervention to remove it from the intracardiac cavity or from the aorta w7, 9, 10x. Even though the present patient was critically ill and had developed a series of complications, surgical management seemed to be the only way for improving his condition.
